"The U.S. Food and Drug Administration approved the Zilver PTX Drug-Eluting Peripheral Stent (Zilver PTX Stent), the first drug-eluting stent indicated to re-open a particular artery in the thigh (femoropopliteal artery) when narrowed or blocked a"...
Sustained Release Capsules, 150 mg
Papaverine hydrochloride, C20H21NO4•HCl, is a white, crystalline powder, odorless, with a slight bitter taste and is soluble in water.
Each capsule contains: papaverine hydrochloride USP 150 mg.
Chemically, it is Isoquinoline,1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-, hydrochloride. It has a molecular weight of 375.85. It has the following structural formula:
Manufactured in a special base which is designed for prolonged release. Each capsule also contains the following inactive ingredients: FD&C blue No. 1, FD&C red No. 40, gelatin, pharmaceutical glaze, povidone, silicon dioxide, sodium lauryl sulfate, corn starch, sucrose and talc.
What are the possible side effects of papaverine (Papacon, Para-Time S. R., Pavabid Plateau, Pavacot, Pavagen)?
Stop taking papaverine and seek emergency medical attention if you experience an allergic reaction (difficulty breathing; closing of your throat; swelling of your lips, tongue, or face; or hives).
Stop taking papaverine and contact your doctor if your skin or eyes develop a yellow tint.
Other, less serious side effects may be more likely to occur. Continue to take papaverine and talk to your doctor if you experience
- nausea, decreased appetite, diarrhea, or constipation;
- dizziness or...
Last reviewed on RxList: 3/31/2009
This monograph has been modified to include the generic and brand name in many instances.
Additional Papaverine Information
Report Problems to the Food and Drug Administration
Get the latest treatment options.